ANAPTYSBIO, INC — Director's Dealing 2017

Aug 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-08-22

Reporting Person: Ware J. Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-22	Director Stock Option (right to buy)	$21.45	A	28571	Acquired	2027-08-21	Common Stock (28571)	Direct
2017-08-22	Director Stock Option (right to buy)	$21.45	A	10694	Acquired	2027-08-21	Common Stock (10694)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 36 equal monthly installments beginning on September 22, 2017, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

F2: The stock option vests and becomes fully exercisable on May 30, 2018.